Picture of Sensorion SA logo

ALSEN Sensorion SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-3.5%
3m-19.86%
6m+19.79%
1yr+129.46%
Volume Change (%)
10d/3m-79.94%
Price vs... (%)
52w High-30.96%
50d MA-5.72%
200d MA+14.95%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-61.59%
Return on Equity-80%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sensorion SA EPS forecast chart

Profile Summary

Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
May 25th, 2009
Public Since
April 21st, 2015
No. of Employees
50
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
187,080,794

ALSEN Share Price Performance

Upcoming Events for ALSEN

Sensorion SA Annual Shareholders Meeting

Sensorion SA Ordinary Shareholders Meeting

Sensorion SA Annual Shareholders Meeting

Half Year 2024 Sensorion SA Earnings Release

Similar to ALSEN

Picture of Abionyx Pharma SA logo

Abionyx Pharma SA

fr flag iconEuronext - Paris

Picture of Abivax SA logo

Abivax SA

fr flag iconEuronext - Paris

Picture of Acticor Biotech SA logo

Acticor Biotech SA

fr flag iconEuronext - Paris

Picture of Adocia SA logo

Adocia SA

fr flag iconEuronext - Paris

Picture of Biophytis SA logo

Biophytis SA

fr flag iconEuronext - Paris

FAQ